Table 9.

Comparing thresholds – probabilistic results

Thresholds	1.8 mmol/L	2.0 mmol/L	2.2 mmol/L
Mean QALYs	6.116	6.080	6.048
Proportion of people requiring ezetimibe	50.6%	42.3%	31.2%
Proportion of people requiring inclisiran	31.2%	18.8%	13.2%
Probability cost-effective at £20,000 per QALY	3%	38%	59%

Note: costs are not reported in the any table due to the confidentiality agreement on the price of inclisiran